Rta, mainly encoded by open reading frame 50 (ORF50), is the product of an immediate-early gene of human herpesvirus-8 (HHV-8)/Kaposi’s sarcoma-associated herpesvirus. Rta is a transcriptional activator that is both necessary and sufficient to disrupt viral latency and activate the expression of downstream viral lytic genes. We report that ectopically expressed Rta protein could also activate the rta promoter on a reporter plasmid up to 144-fold, both in latently infected B cells and in uninfected epithelial cells, and that this activation was dose-dependent. Furthermore, by analysing the 5′ untranslated region using ribonuclease protection assays, we demonstrated that transfection of an Rta expression plasmid into latently infected cells activated the expression of rta transcripts from endogenous viral genomes. We propose that auto-activation of the immediate-early gene, rta, is an important strategy for HHV-8 to effectively respond to environmental stimuli and maximally activate the virus lytic cycle.
ArvanitakisL.,
MesriE. A.,
NadorR. G.,
SaidJ. W.,
AschA. S.,
KnowlesD. M.,
CesarmanE.1996; Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi’s sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein–Barr virus. Blood 88:2648–2654
BoshoffC.,
GaoS. J.,
HealyL. E.,
MatthewsS.,
ThomasA. J.,
CoignetL.,
WarnkeR. A.,
StrauchenJ. A.,
MatutesE.,
KamelO. W.,
MooreP. S.,
WeissR. A.,
ChangY.1998; Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood 91:1671–1679
CesarmanE.,
ChangY.,
MooreP. S.,
SaidJ. W.,
KnowlesD. M.1995a; Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New England Journal of Medicine 332:1186–1191
CesarmanE.,
MooreP. S.,
RaoP. H.,
InghiramiG.,
KnowlesD. M.,
ChangY.1995b; In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi’s sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86:2708–2714
Chevallier-GrecoA.,
ManetE.,
ChavrierP.,
MosnierC.,
DaillieJ.,
SergeantA.1986; Both Epstein–Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO Journal 5:3243–3249
CoxM. A.,
LeahyJ.,
HardwickJ. M.1990; An enhancer within the divergent promoter of Epstein–Barr virus responds synergistically to the R and Z transactivators. Journal of Virology 64:313–321
GruffatH.,
Portes-SentisS.,
SergeantA.,
ManetE.1999; Kaposi’s sarcoma-associated herpesvirus (human herpesvirus-8) encodes a homologue of the Epstein–Barr virus bZip protein EB1. Journal of General Virology 80:557–561
HardwickJ. M.,
LiebermanP. M.,
HaywardS. D.1988; A new Epstein–Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. Journal of Virology 62:2274–2284
Holley-GuthrieE. A.,
QuinlivanE. B.,
MarE. C.,
KenneyS.1990; The Epstein–Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell- specific manner. Journal of Virology 64:3753–3759
LinS. F.,
RobinsonD. R.,
MillerG.,
KungH. J.1999; Kaposi’s sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein–Barr virus. Journal of Virology 73:1909–1917
LukacD. M.,
RenneR.,
KirshnerJ. R.,
GanemD.1998; Reactivation of Kaposi’s sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252:304–312
LukacD. M.,
KirshnerJ. R.,
GanemD.1999; Transcriptional activation by the product of open reading frame 50 of Kaposi’s sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. Journal of Virology 73:9348–9361
MillerG.,
HestonL.,
GroganE.,
GradovilleL.,
RigsbyM.,
SunR.,
SheddD.,
KushnaryovV. M.,
GrossbergS.,
ChangY.1997; Selective switch between latency and lytic replication of Kaposi’s sarcoma herpesvirus and Epstein–Barr virus in dually infected body cavity lymphoma cells. Journal of Virology 71:314–324
NicholasJ.,
ColesL. S.,
NewmanC.,
HonessR. W.1991; Regulation of the herpesvirus saimiri (HVS) delayed-early 110- kilodalton promoter by HVS immediate-early gene products and a homolog of the Epstein–Barr virus R trans activator. Journal of Virology 65:2457–2466
NicholasJ.,
RuvoloV.,
ZongJ.,
CiufoD.,
GuoH. G.,
ReitzM. S.,
HaywardG. S.1997; A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. Journal of Virology 71:1963–1974
RagoczyT.,
HestonL.,
MillerG.1998; The Epstein–Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. Journal of Virology 72:7978–7984
RussoJ. J.,
BohenzkyR. A.,
ChienM. C.,
ChenJ.,
YanM.,
MaddalenaD.,
ParryJ. P.,
PeruzziD.,
EdelmanI. S.,
ChangY.,
MooreP. S.1996; Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proceedings of the National Academy of Sciences, USA 93:14862–14867
SaidW.,
ChienK.,
TakeuchiS.,
TasakaT.,
AsouH.,
ChoS. K.,
de VosS.,
CesarmanE.,
KnowlesD. M.,
KoefflerH. P.1996; Kaposi’s sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells. Blood 87:4937–4943
SaridR.,
FloreO.,
BohenzkyR. A.,
ChangY.,
MooreP. S.1998; Transcription mapping of the Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). Journal of Virology 72:1005–1012
SeamanW. T.,
YeD.,
WangR. X.,
HaleE. E.,
WeisseM.,
QuinlivanE. B.1999; Gene expression from the ORF50/K8 region of Kaposi’s sarcoma-associated herpesvirus. Virology 263:436–449
SunR.,
LinS. F.,
GradovilleL.,
YuanY.,
ZhuF.,
MillerG.1998; A viral gene that activates lytic cycle expression of Kaposi’s sarcoma-associated herpesvirus. Proceedings of the National Academy of Sciences, USA 95:10866–10871
van SantenV. L.1993; Characterization of a bovine herpesvirus 4 immediate-early RNA encoding a homolog of the Epstein–Barr virus R transactivator. Journal of Virology 67:773–784
VieiraJ.,
HuangM. L.,
KoelleD. M.,
CoreyL.1997; Transmissible Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi’s sarcoma. Journal of Virology 71:7083–7087
WhitehouseA.,
CarrI. M.,
GriffithsJ. C.,
MeredithD. M.1997; The herpesvirus saimiri ORF50 gene, encoding a transcriptional activator homologous to the Epstein–Barr virus R protein, is transcribed from two distinct promoters of different temporal phases. Journal of Virology 71:2550–2554
WuT. T.,
UsherwoodE. J.,
StewartJ. P.,
NashA. A.,
SunR.2000; Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency. Journal of Virology 74:3659–3667
ZalaniS.,
Holley-GuthrieE.,
KenneyS.1996; Epstein–Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proceedings of the National Academy of Sciences, USA 93:9194–9199
ZhongW.,
WangH.,
HerndierB.,
GanemD.1996; Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proceedings of the National Academy of Sciences, USA 93:6641–6646
ZhuF. X.,
CusanoT.,
YuanY.1999; Identification of the immediate-early transcripts of Kaposi’s sarcoma-associated herpesvirus. Journal of Virology 73:5556–5567